{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03695185: Phase 2 Interventional Completed Ulcerative Colitis (UC)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04082936: Phase 1/Phase 2 Interventional Terminated Non-Hodgkin Lymphoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dargistotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04287985: Phase 2 Interventional Completed Immunoglobulin A Nephropathy
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03893955: Phase 1 Interventional Active, not recruiting Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03411915: Phase 1 Interventional Completed Neuroendocrine Tumor
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03849651: Phase 2 Interventional Active, not recruiting Acute Lymphoblastic Leukemia (ALL)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03060538: Phase 1 Interventional Completed Diabetes Mellitus, Type 2
(2017)
Source URL:
Class:
PROTEIN
